QCi and INmune Bio partner to study XPro in Alzheimer’s

PartnershipXProPositive

AI Analysis

Summary

INmune Bio and QCi announced a collaboration to explore new indications for XPro using quantum computing, AI, and data analytics. The partnership aims to advance the investigational Alzheimer's disease treatment.

Importance:5/10

Sentiment:

0.30

partnershipcollaborationquantum computingAIAlzheimer'sXPro

Related Companies

$INMB

Read the original article

Published by Pharmaceutical Technology on October 15, 2026 9:59 AM

Read Original